Clinical Trial Update: Pharmacokinetics and Safety Study of Levornidazole Disodium Phosphate for Injection in Subjects With Renal Impairment and Normal Renal Impairment [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and safety study of Levornidazole disodium phosphate for injection in subjects with renal impairment and normal renal function has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infections Caused By Anaerobic Bacteria

Drugs mentioned

• Levornidazole disodium phosphate for injection (levornidazole disodium phosphate)

Snippet

Sponsor: Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd | Conditions: Infections Caused by Anaerobic Bacteria, Renal Impairment | Phase 1 | Status: COMPLETED